Workflow
坏账准备
icon
Search documents
*ST元成: 关于元成环境股份有限公司2024年年度报告的信息披露监管工作函中的有关问题的专项说明
Zheng Quan Zhi Xing· 2025-06-20 10:40
中兴财光华会计师事务所(特殊普通合伙)关于 元成环境股份有限公司 2024 年年度 报告的信息披露监管工作函中的有关问题的专项说明 中兴财光华会计师事务所(特殊普通合伙)关于 元成环境股份有限公司 2024 年年度 报告的信息披露监管工作函中的有关问题的专项说明 上海证券交易所上市公司管理二部: 贵部《关于元成环境股份有限公司 2024 年年度报告的信息披露监管工作函》 (以下简称"工作函")收悉。中兴财光华会计师事务所(特殊普通合伙)(以 下简称"我们")是元成环境股份有限公司(以下简称"元成股份"或"公司") 发表意见的问题进行了审慎核查,现将情况汇报如下: 一、关于经营情况。年报显示,2024 年度公司实现营业收入 1.46 亿元,同 比下降 46.79%,扣非前后的净利润分别亏损 3.25 亿元、3.23 亿元,同比亏损幅度 加大。公司称主要受行业周期波动影响主要业务收缩导致营业收入下滑、计提减 值损失增加等使净利润减少。分产品看,除苗木销售及电子设备及元器件外,公 司工程施工及绿化养护、规划设计等主营业务毛利率分别为-27.94%、-14.27%,同 比大幅下滑。分季度看,公司第四季度实现营收 1. ...
麒盛科技: 天健会计师事务所(特殊普通合伙)关于麒盛科技股份有限公司2024年年度报告信息披露监管问询函的专项说明
Zheng Quan Zhi Xing· 2025-06-19 13:17
| | | | 一、关于非标审计意见及关联方追加认定………………………第 | 1—20 页 | | --- | --- | | 二、关于应收账款 ………………………………………………第 | 20—25 页 | | 三、关于在建工程 ………………………………………………第 | 25—49 页 | | 问询函专项说明 | | 天健函〔2025〕629 号 上海证券交易所: 由麒盛科技股份有限公司(以下简称麒盛科技公司或公司)转来的《关于对 麒盛科技股份有限公司 2024 年年度报告的信息披露监管问询函》(上证公函 〔2025〕0616 号,以下简称问询函)奉悉。我们已对问询函中需要我们说明的 财务事项进行了审慎核查,现汇报说明如下。 一、关于非标审计意见及关联方追加认定 公司财务报告审计意见为带强调事项段的无保留意见,强调事项涉及对上海 舒福德数字科技有限公司(以下简称上海舒福德)的应收款项面临损失风险并计 提坏账准备。截至 2024 年末,公司对上海舒福德的应收账款余额 9,478.67 万 元、其他应收款余额 2,026.35 万元,公司分别对其单项计提坏账准备 6,678.67 万元、2,026.35 万元 ...
鲁抗医药: 和信会计师事务所(特殊普通合伙)关于山东鲁抗医药股份有限公司向特定对象发行股票申请文件的审核问询函的回复
Zheng Quan Zhi Xing· 2025-06-17 13:25
Core Viewpoint - The report discusses the financial performance and operational changes of Shandong Lukang Pharmaceutical Co., Ltd., highlighting significant growth in sales net profit margin and the impact of asset disposal on profitability [1][11]. Financial Performance - The company's operating revenue for the reporting periods was 562.14 million yuan, 614.67 million yuan, and 623.31 million yuan, with net profits of 13.80 million yuan, 24.62 million yuan, and 40.83 million yuan respectively [1][2]. - The sales net profit margins increased from 2.55% in 2022 to 4.18% in 2023, and further to 6.55% in 2024, primarily due to changes in product structure and asset disposal gains [3][11]. Gross Margin Analysis - The comprehensive gross margins for the reporting periods were 22.19%, 24.65%, and 23.96%, with the main business gross margin contributing significantly to overall profitability [3][4]. - The gross margin for the human medicine segment showed a steady increase, with the formulation drug gross margin rising from 33.68% to 41.46% over the reporting periods [4][5]. Cost Structure - The operating costs for the company were 473.95 million yuan, 463.13 million yuan, and 437.40 million yuan, indicating a controlled cost structure relative to revenue growth [2][6]. - Direct material costs accounted for approximately 75.45% of total revenue, reflecting the significant impact of raw material prices on overall profitability [6][8]. Market Competition and Product Performance - The raw material drug gross margin fluctuated, showing a decline in 2023 due to market competition, followed by a recovery in 2024 [5][9]. - The veterinary medicine segment experienced variable gross margins, influenced by market demand and competition, with margins of 15.66%, 18.16%, and 13.23% over the reporting periods [9][10]. Asset Disposal Impact - The company realized substantial asset disposal gains in 2024, amounting to 283.26 million yuan, significantly boosting net profit and sales net profit margin [9][10]. - The asset disposal was linked to the completion of land storage for the southern plant area, which was part of a strategic relocation initiative [10][11]. Export and Revenue Matching - The customs declaration data matched closely with overseas revenue, with minor discrepancies deemed reasonable due to small sample exports and timing differences [13][14]. - The company’s overseas revenue was diversified across several countries, including the UK, Netherlands, and Egypt, with stable trade and tariff policies [16][17]. Sales Expenses - The sales expense ratios were 8.45%, 9.40%, and 9.11%, significantly lower than the industry average, indicating efficient cost management in sales promotion [19][20]. - The increase in promotional expenses from 2023 was attributed to strategic marketing efforts to enhance product visibility and market share [19].
每周股票复盘:龙软科技(688078)2024年净利润下降60.83%
Sou Hu Cai Jing· 2025-06-14 06:53
Company Performance - Longsoft Technology reported a net profit of 33.03 million yuan for 2024, a year-on-year decline of 60.83% due to decreased coal industry prosperity [2][4] - The company's operating revenue for 2024 was 329 million yuan, down 17.04% year-on-year, with smart mining industrial software contributing 84.21% of total revenue [3][4] - In Q4 2024, the company achieved operating revenue of 114 million yuan, a year-on-year decrease of 20.93%, and reported a net loss of 16.02 million yuan [3] Dividend Announcement - Longsoft Technology announced a cash dividend of 0.136 yuan per share, with the record date set for June 16, 2025, and the payment date on June 17, 2025 [1][4] - The total cash dividend distribution amounts to approximately 9.91 million yuan based on the total share capital of 72,893,000 shares [1] Accounts Receivable - The accounts receivable balance for the company was 397 million yuan in 2022, 507 million yuan in 2023, and 506 million yuan in 2024, representing 49.69%, 56.21%, and 53.83% of total assets respectively [3] - The company recognized bad debt provisions of 28.24 million yuan during the reporting period, with an ending balance of 127 million yuan [3] Tax Matters - For individual shareholders holding unrestricted shares for over one year, dividend income is exempt from personal income tax; for those holding less than one year, tax is deferred until the stock is sold [2] - The company has withheld a 10% tax on cash dividends for certain investors, including QFIIs and Hong Kong market investors [2]
中国第一重型机械股份公司关于上海证券交易所对公司年报信息披露监管问询函的回复公告
登录新浪财经APP 搜索【信披】查看更多考评等级 证券代码:601106 证券简称:中国一重(维权) 公告编号:2025-031 中国第一重型机械股份公司关于上海证券交易所对公司年报信息披露监管问询函的回复公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者重大遗漏,并对其内容 的真实性、准确性和完整性承担个别及连带责任。 中国第一重型机械股份公司(以下简称中国一重或公司),于2025年5月22日收到上海证券交易所上市 公司管理一部下发的《关于中国第一重型机械股份公司2024年年度报告的信息披露监管问询函》(上证 公函〔2025〕0621号)(以下简称《问询函》),公司收到《问询函》后,高度重视,积极组织相关部 门对《问询函》所述事项逐项落实并回复。现对《问询函》所述事项回复公告如下: 问题一:关于应收账款与合同资产。 按单项计提坏账准备的应收账款前十名情况如下: 单位:亿元 ■ 相关业务开展前的尽调措施:相关业务开展前,公司通过国家企业信用信息公示系统核实企业名称、注 册号、注册资本、实缴资本、成立日期、营业期限、经营范围、法定代表人、股东及出资情况、注册地 址等,重点关注客户是否存 ...
云南城投: 云南城投置业股份有限公司关于上海证券交易所2024年年报问询的回复
Zheng Quan Zhi Xing· 2025-06-13 09:42
证券代码:600239 证券简称:云南城投 公告编号:临 2025-039 号 云南城投置业股份有限公司 关于上海证券交易所 2024 年年报问询的回复 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者 重大遗漏,并对其内容的真实性、准确性和完整性承担法律责任。 云南城投置业股份有限公司(下称"公司")于近日收到上海证券交易所《关于 云南城投置业股份有限公司 2024 年年度报告的信息披露监管工作函》(上证公函 【2025】0543 号)。公司同年审会计师就相关内容回复如下: 一、关于信用减值。年报显示,2024 年公司确认信用减值损失 2,398.59 万元, 主要为单项计提的坏账准备,较 2023 年同比增长 403.51%,减值损失增幅明显大于 各应收类款项余额增幅。关注到,期末余额前五名的应收账款均为公司关联方,公司 将关联方及部分自然人应收账款分类为无风险组合的应收账款未计提坏账;期末余额 前五名的其他应收款余额合计 3.75 亿元,主要为应收土地补偿款、往来款和保证金, 账龄均在 4 年以上,公司仅计提坏账准备 0.36 亿元,坏账准备计提比例不足 10%, 公司账龄 3 年 ...
中国一重: 公告2025-031(中国第一重型机械股份公司关于上海证券交易所对公司年报信息披露监管问询函的回复公告)
Zheng Quan Zhi Xing· 2025-06-13 09:30
Core Viewpoint - The company received an inquiry letter from the Shanghai Stock Exchange regarding its annual report disclosure, particularly focusing on accounts receivable and contract assets, which are significant factors in its financial performance and potential risks [1]. Group 1: Accounts Receivable - The company's accounts receivable at the end of the period amounted to 7.323 billion, with a cumulative provision for bad debts of 3.811 billion, and a current period provision for bad debts of 1.091 billion, which is a major reason for the company's losses this year [2]. - The provision for bad debts on accounts receivable increased by approximately 1.215 billion compared to the previous year, with a total of 2.787 billion provided on a single-item basis [2]. - The company was asked to disclose detailed information regarding the top ten accounts receivable, including transaction details, payment history, aging of receivables, and credit management measures [2][3]. Group 2: Contract Assets - The company's contract assets at the end of the reporting period were valued at 5.231 billion, with a cumulative provision for bad debts of 0.094 billion, representing a provision rate of only 1.8% [2]. - The company was requested to provide details on the top five contract assets, including project names, transaction details, counterparties, contract amounts, aging, and expected settlement times [2]. - The company has a structured approach to classify customers based on their credit risk, which influences the provision for bad debts [16]. Group 3: Inventory - The company's inventory at the end of 2024 was recorded at 8.630 billion, reflecting a year-on-year increase of 6.44%, with work-in-progress and finished goods accounting for 6.621 billion [19]. - The increase in inventory is attributed to the long production cycles of the company's products, which are primarily custom-made for large enterprises [19][22]. - The company has identified specific reasons for inventory aging beyond typical production cycles, including project delays and new product failures, and has taken measures to assess and provision for potential inventory impairments [23][25].
股市必读:交建股份(603815)新发布《容诚会计师事务所(特殊普通合伙)关于安徽省交通建设股份有限公司2024年年度报告的信息披露监管问询函相关问题的核查意见》
Sou Hu Cai Jing· 2025-06-08 18:11
截至2025年6月6日收盘,交建股份(603815)报收于7.16元,上涨1.42%,换手率1.53%,成交量9.46万 手,成交额6732.6万元。 当日关注点 业绩承诺期内净利润:2021年至2023年,祥源建设(后更名为交建工程)业绩承诺期内净利润分 别为4068.48万元、3447.63万元、6053.30万元,累计完成率113%。 关联销售收入占比:关联销售收入占比逐年下降,从95.07%降至50.23%。 营业收入与净利润:2024年,交建工程实现营业收入69136.78万元,净利润1457.40万元,关联销 售收入减少至21232.27万元。 控股股东抵偿:控股股东祥源控股以82套房产抵偿1.32亿元施工工程款,大部分房产已完成处 置,未发生减值。 坏账准备:公司对海口城中城建项目管理公司应收账款单项计提坏账准备6559.90万元,其他应收 款期末余额2.86亿元,计提坏账6733.30万元,其中关联方2986.75万元。 其他非流动资产:应收关联方其他非流动资产5919.53万元,为未到期质保金。 以上内容为证券之星据公开信息整理,由AI算法生成(网信算备3101043457103012400 ...
*ST开元: 关于深圳证券交易所《关于对开元教育科技集团股份有限公司的年报问询函》回复的公告
Zheng Quan Zhi Xing· 2025-06-06 14:12
证券代码:300338 证券简称:*ST 开元 公告编号:2025-042 开元教育科技集团股份有限公司 关于深圳证券交易所《关于对开元教育科技集团股份有限 公司的年报问询函》回复的公告 本公司及董事会全体成员保证公告内容的真实、准确和完整,没有虚假记 载、误导性陈述或重大遗漏。 开元教育科技集团股份有限公司(以下简称"开元教育""上市公司""本 公司或"公司")于 2025 年 4 月 28 日披露了《2024 年年度报告》,并于 2025 年 5 月 6 日收到贵部下发的《关于对开元教育科技集团股份有限公司的年报问询 函》(创业板年报问询函【2025】第 24 号),公司现根据问询函所涉问题进行 说明、解释和回复,具体内容如下。 如无特别说明,本回复的词语或简称与《2024 年年度报告》"释义"中所定义 的词语或简称具有相同的含义。 本说明中部分合计数与各项目相加之和可能存在尾数差异,这些差异系四舍 五入所致。本报告中涉及货币金额的单位,如无特别指明,均为人民币万元。 问题一: 中,学历中介业务实现收入 0.17 亿元,同比增长 6.99%,发生成本 0.1 亿元,同 比增长 43.15%;教育培训业务实 ...
五洲交通: 致同会计师事务所关于广西五洲交通股份有限公司2024年年报问询函的回复
Zheng Quan Zhi Xing· 2025-06-06 10:37
关于广西五洲交通股份有限公司 致同会计师事务所(特殊普通合伙) 致同会计师事务所(特殊普通合伙) 中国北京 朝阳区建国门外大街 22 号 赛特广场 5 层 邮编 100004 电话 +86 10 8566 5588 传真 +86 10 8566 5120 www.grantthornton.cn 关于广西五洲交通股份有限公司 致同专字(2025)第 450A015827 号 上海证券交易所: 致同会计师事务所(特殊普通合伙)(以下简称"我们")接受委托对广 西五洲交通股份有限公司(以下简称"公司"或"五洲交通")2024 年财务报 表,包括 2024 年 12 月 31 日的合并及公司资产负债表,2024 年度的合并及公司 利润表、合并及公司现金流量表、合并及公司股东权益变动表以及相关财务报 表附注进行审计,并于 2025 年 3 月 28 日出具了致同审字(2025)第 450A005536 号的无保留意见审计报告。 我们于 2025 年 5 月 9 日收到了公司转来的上海证券交易所(以下简称"上 交所")出具的《关于广西五洲交通股份有限公司 2024 年年度报告的信息披露 监管问询函》(上证公函【2025 ...